SMI Expanded
1.638,96
PKT
-2,44
PKT
-0,15
%
Werbung
Analysen zu SMI Expanded-Werten
Datum | Rating | Analyst | |
---|---|---|---|
15.01.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
12.01.24 | Richemont Buy | Deutsche Bank AG | |
12.01.24 | Richemont Buy | Jefferies & Company Inc. | |
12.01.24 | Swiss Re Overweight | JP Morgan Chase & Co. | |
12.01.24 | Richemont Sector Perform | RBC Capital Markets | |
12.01.24 | ams-OSRAM Outperform | Bernstein Research | |
11.01.24 | UBS Outperform | RBC Capital Markets | |
11.01.24 | Richemont Buy | Goldman Sachs Group Inc. | |
11.01.24 | Richemont Overweight | JP Morgan Chase & Co. | |
11.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
11.01.24 | Givaudan Underperform | Jefferies & Company Inc. | |
11.01.24 | Swiss Re Sector Perform | RBC Capital Markets | |
10.01.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
10.01.24 | Nestlé Overweight | JP Morgan Chase & Co. | |
10.01.24 | Holcim Neutral | Merrill Lynch & Co., Inc. | |
10.01.24 | ams-OSRAM Buy | Jefferies & Company Inc. | |
10.01.24 | Zurich Insurance Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
10.01.24 | Givaudan Market-Perform | Bernstein Research | |
10.01.24 | ams-OSRAM Equal Weight | Barclays Capital | |
09.01.24 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
09.01.24 | Roche Equal Weight | Barclays Capital | |
09.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
09.01.24 | Givaudan Market-Perform | Bernstein Research | |
08.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
08.01.24 | Novartis Neutral | UBS AG | |
08.01.24 | Richemont Sector Perform | RBC Capital Markets | |
08.01.24 | DocMorris Equal-weight | Morgan Stanley | |
05.01.24 | UBS Outperform | RBC Capital Markets | |
05.01.24 | Novartis Buy | Deutsche Bank AG | |
05.01.24 | DocMorris Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
04.01.24 | Swiss Re Sector Perform | RBC Capital Markets | |
04.01.24 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
03.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
03.01.24 | Richemont Buy | UBS AG | |
03.01.24 | Novartis Buy | Jefferies & Company Inc. | |
03.01.24 | Roche Hold | Jefferies & Company Inc. | |
02.01.24 | DocMorris Buy | Jefferies & Company Inc. | |
02.01.24 | Richemont Outperform | Bernstein Research | |
02.01.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
02.01.24 | Roche Underweight | JP Morgan Chase & Co. |